| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $3.51 | $3.43 | $3.76 | $3.47 | $2.81 | $0.54 | $2.84 | $3.03 |
| EPS (Diluted) | $3.49 | $3.41 | $3.74 | $3.46 | $2.81 | $0.62 | $0.62 | $0.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.9B | $9.7B | $9.6B | $9.1B | $9.5B | $9.0B | $8.8B | $7.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.9B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $8.4B | $8.3B | $8.3B | $7.9B | $8.3B | $7.8B | $7.6B | $6.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.5B | $1.4B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.4B | $-0.4B | $0.0B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.1B | $-0.0B | $0.3B | $-0.6B | $0.5B | $0.1B | $0.1B | $0.1B |